Glimepiride; Rosiglitazone Maleate is Used for improving glycemic control in adult patients with type 2 diabetes mellitus who are naive to pharmacologic therapy. It was first introduced by Sb Pharmco Puerto Rico Inc in its drug Avandaryl on Nov 23, 2005. 2 different companies have introduced drugs containing Glimepiride; Rosiglitazone Maleate.

Glimepiride; Rosiglitazone Maleate Patents

Given below is the list of patents protecting Glimepiride; Rosiglitazone Maleate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Avandaryl	US7358366 (Pediatric)	Thiazolidinedione derivative and its use as antidiabetic	Oct 19, 2020 (Expired)	Sb Pharmco
Avandaryl	US7358366	Thiazolidinedione derivative and its use as antidiabetic	Apr 19, 2020 (Expired)	Sb Pharmco
Avandaryl	US5741803 (Pediatric)	Substituted thiazolidinedionle derivatives	Oct 21, 2015 (Expired)	Sb Pharmco
Avandaryl	US5741803	Substituted thiazolidinedionle derivatives	Apr 21, 2015 (Expired)	Sb Pharmco

Add above patents to watchlist

Glimepiride; Rosiglitazone Maleate's Family Patents

Full family tree

Glimepiride; Rosiglitazone Maleate Generic API Manufacturers

Several generic applications have been filed for Glimepiride; Rosiglitazone Maleate.

Given below is the list of companies who have filed for Glimepiride; Rosiglitazone Maleate generic, along with the locations of their manufacturing plants worldwide.